期刊文献+

磷霉素联合4种抗菌药物对泛耐药鲍氏不动杆菌体外活性研究 被引量:4

Study on antibacterial activity in vitro of fosfomycin combined with four antibiotics against extensively drug-resistant Acinetobacter baumannii
原文传递
导出
摘要 目的探讨磷霉素(FOS)与4种临床常用抗菌药物联合应用,以增强临床分离泛耐药鲍氏不动杆菌(XDRAB)体外抗菌活性。方法收集临床分离的XDRAB 50株,采用微量肉汤法和棋盘法测定FOS与左氧氟沙星、美罗培南、阿米卡星及头孢哌酮/舒巴坦4种常用抗菌药物联合使用的最低抑菌浓度(MIC),计算其部分抑菌浓度指数(FIC);用扫描电镜对比观察药物单用和联用时细菌形态变化。结果 4种抗菌药物与FOS联合使用在体外对XDRAB抗菌活性较单用增强,FOS联用美罗培南FIC值显示协同与相加作用分别占32%和46%;FOS联用左氧氟沙星(LVX)占58%和26%;FOS联用头孢哌酮/舒巴坦(CFS)占32%和54%;FOS联用阿米卡星(AMK)则占44%和38%;FIC值显示FOS与4种抗菌药物联合使用,协同与相加作用约占80%;扫描电镜观察到1/4MIC浓度的FOS单用时,细菌肿胀变形,而与其他4种抗菌药物1/4MIC联用时,细菌变形坏死。结论联合使用FOS能增强左氧氟沙星、美罗培南、阿米卡星及头孢哌酮/舒巴坦4种抗菌药物对XDRAB的抗菌活性。 OBJECTIVE To evaluate the in vitro activity of fosfomycin(FOS)in combination with four antibiotics against extensively drug-resistant A.baumannii(XDRAB)so as to intensify the in vitro antimicrobial activity of the XDRAB.METHODS Totally 50 strains of XDRAB isolated in clinic were collected.The minimal inhibitory concentrations(MICs)of FOS combined with levofloxacin,meropenem,cefperazone-sulbactam(SCF)/sulbactam and amikacin(AMK)was detected by microdilution method and chessboard method.The fractional inhibitory concentration index(FIC)was calculated according to MIC results.Morphological changes of A.baumannii was observed by scanning electron microscope.RESULTS The four antibiotics had strengthened their antibacterial activity when combined with FOS.The FIC value showed synergy or additive effect.The result showed that the additive effect of FOS+MER,FOS+LVX,FOS+CFS,FOS+AMK were 32% and 46%,58% and 26%,32% and 54%,44% and 38%respectively.They were around 80%in synergy effect and additive effect when FOS was combined with four kinds of antibiotics showed by FIC values.Antagonism effect was not observed for any combination.Scanning electron microscope founded when 1/4MIC of fosfomycin was singly used,A.baumannii became swelling and distorted,but when combined with the 4kinds of antibiotics,most of the A.baumannii distorted and died.CONCLUSIONFosfomycin will have higher antibacterial activity against XDRAB when combined with the 4kinds of antibiotics.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2015年第14期3199-3201,共3页 Chinese Journal of Nosocomiology
基金 国家自然科学基金资助项目(81260663) 广西急诊与医学救援人才小高地基金项目(GXZJ201402)
关键词 鲍氏不动杆菌 泛耐药 联合用药 磷霉素 Acinetobacter baumannii Extensively drug-resistant Drug combination Fosfomycin
  • 相关文献

参考文献5

  • 1Sui W, Wang J, Wang H, et al. Comparing the transmission potential of methieillin-resistant Staphylococcus aureus and multidrug-resistant Acinetobacter baumannii among inpatients using target environmental monitoring[J]. Am J Infect Con- trol,2013,41(5) :411-415. 被引量:1
  • 2Roca I,Espinal P,Vila-Farres X,etal. The Acinetobacterbauman- nii oxymoron= commensal hospital dweller turned pan-drug-resist- ant mermce[J]. Front Mierobiol,2012,3(148) : 1-30. 被引量:1
  • 3Howard A, O'Donoghue M, Feeney A, et al. Acinetobacter bau- mannii: an emerging opportunistic pathogen[J]. Virulence,2012, 3(3) :243-250. 被引量:1
  • 4Raz R. Fosfomyein: an old-new antibiotic[J]. Clin Microbiol Infect,2012,18(1) :4-7. 被引量:1
  • 5Samonis G, Maraki S,Karageorgopoulos DE,et al. Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tige- cycline against multidrug-resistant Klebsiella pneurnoniae, Escherichia coli ,and Pseudomonas aeruginosa clinical isolates [J]. Eur J Clin Microbiol Infect Dis,2012,31(5) :695-701. 被引量:1

同被引文献34

  • 1黄祥,王健民,李勇.磷霉素的药动学药效学特性与临床应用[J].中国医院药学杂志,2005,25(2):156-158. 被引量:61
  • 2Karumathil DP, Yin HB, Kollanoor-Johny A, et al. Effect of Chlorine exposure on the survival and antibiotic gene expression of multidrug resistant Acinetobacter baumannii in water[J].Int J Environ Res Public Health, 2014, 11 (2) :1844-1854. 被引量:1
  • 3Era B, Yilmaz FF, HosgOr LM, et al. Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates [J]. Mikrobiyol Bul, 2014,48 ( 1 ) : 70-81. 被引量:1
  • 4Clinical and Laboratory Standards Institute. M100-S25 Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Fifth Informational Supplement [S]. Wayne. PA : CLSI, 2015. 被引量:1
  • 5Rosa R, Arheart KL, Depascale D, et al. Environmental exposure to carbapenem-resistant Acinetobacter bauman- nii as a risk factor for patient acquisition of A. baumannii [J]. Infect Control Hosp Epidemiol, 2014, 35 (4): 430- 433. 被引量:1
  • 6Dinc G,Demiraslan H, Elmali F, et al. Efficacy of sulbac tam and its combination with imipenem,colistin and tige- cycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis[J].Chemotherapy,2013, 59(5) : 325-329. 被引量:1
  • 7Batirel A,Balkan II,Karabay O,et al. Comparison of co- listin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobaeter baumannii bloodstream in- fections[J].Eur J Clin Microbiol Infect Dis, 2014,33 (8) : 1311-1322. 被引量:1
  • 8汪复,朱德妹,胡付品,阮斐怡,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,李丽,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,薛建昌,张泓,李万华,徐元宏,沈继录,单斌,杜艳.2009年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2010,10(5):325-334. 被引量:397
  • 9鲍滨.ICU鲍氏不动杆菌感染特点及耐药性变迁[J].中华医院感染学杂志,2011,21(24):5271-5273. 被引量:2
  • 10陈佰义,何礼贤,胡必杰,倪语星,邱海波,石岩,施毅,王辉,王明贵,杨毅,张菁,俞云松.中国鲍曼不动杆菌感染诊治与防控专家共识[J].中华医学杂志,2012,92(2):76-85. 被引量:843

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部